Wendy P. Bannister
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Factors Associated with Persistently Increased IL-6 Levels in People with HIV.
Journal: The Journal of infectious diseases
Published: June 24, 2026
Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway Analysis.
Journal: Open forum infectious diseases
Published: December 04, 2025
Trends in AIDS-defining illnesses among people living with HIV in clinical care in Europe: results from the EuroSIDA multicentre cohort study (2003-24).
Journal: The lancet. HIV
Published: October 31, 2025
Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 22, 2024
SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort.
Journal: HIV medicine
Published: December 17, 2023
Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE).
Journal: Open forum infectious diseases
Published: March 22, 2023
Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens.
Journal: AIDS (London, England)
Published: July 18, 2022
Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours.
Journal: Infection
Published: October 12, 2021
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
Journal: British journal of clinical pharmacology
Published: November 04, 2019
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 29, 2019
Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment.
Journal: Clinical pharmacokinetics
Published: March 17, 2019
Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
Journal: Cancer chemotherapy and pharmacology
Published: July 12, 2016
Last Updated: 09/26/2026